NCT07316673

Brief Summary

This prospective randomized clinical trial evaluates the effectiveness of a Fast Fix-enhanced arthroscopic system compared with conventional arthroscopic suturing for temporomandibular joint disc repositioning in patients with TMJ internal derangement. Patients are randomly allocated into two groups and assessed for functional improvement (maximum mouth opening), pain reduction, joint symptoms, and surgical performance outcomes over a 6-month follow-up period. The study aims to determine whether the Fast Fix-enhanced technique provides superior clinical, functional, and surgical outcomes compared to conventional arthroscopic suturing

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
8mo left

Started Jan 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress35%
Jan 2026Jan 2027

First Submitted

Initial submission to the registry

December 19, 2025

Completed
13 days until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 5, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

January 6, 2026

Status Verified

December 1, 2025

Enrollment Period

11 months

First QC Date

December 19, 2025

Last Update Submit

January 2, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Functional improvement assessed by Maximum Mouth Opening (MIO)

    MIO is measured as the maximal interincisal distance (in millimeters) using a ruler or digital caliper, with the primary endpoint being the change from baseline to 6 months postoperatively.

    Baseline (preoperative) to 6 months postoperatively (with assessments at 3 months and 6 months; primary endpoint at 6 months

Secondary Outcomes (4)

  • Clinical outcomes , Pain reduction assessed using the Visual Analogue Scale (VAS) • Improvement of joint symptoms, including clicking and tenderness.

    Baseline (preoperative), 3 months, and 6 months postoperatively

  • Joint Symptoms (Clicking and Tenderness)

    Baseline (preoperative), 3 months, and 6 months postoperatively

  • Surgical outcomes Total surgical time recorded

    Intraoperative (day of procedure only)

  • surgical outcomes Technical Feasibility

    Intraoperative (day of procedure only)

Study Arms (2)

Fast-Fix-Enhanced Arthroscopic Disc Repositioning

EXPERIMENTAL
Procedure: Fast-Fix-Enhanced Arthroscopic

Conventional Arthroscopic Suturing Disc Repositioning

ACTIVE COMPARATOR
Procedure: (Conventional Arthroscopic Suturing Disc Repositioning)

Interventions

Device: The FasT-Fix system is a medical device designed for an "all-inside" arthroscopic meniscal repair.

Fast-Fix-Enhanced Arthroscopic Disc Repositioning

Arthroscopic TMJ discopexy using conventional suturing Minimally invasive surgical intervention

Conventional Arthroscopic Suturing Disc Repositioning

Eligibility Criteria

Age15 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years.
  • Both sexes.
  • Patients with TMJ internal derangement (disc displacement without reduction).
  • Patients indicated for arthroscopic disc repositioning following failure of conservative management.

You may not qualify if:

  • Previous TMJ surgery on the affected joint.
  • Rheumatoid arthritis, systemic inflammatory joint disease, or other TMJ pathology (tumor, fracture, infection)
  • Severe degenerative joint disease (osteoarthritis grade V) or ankylosis.
  • Patients are unable to comply with follow-up assessments or MRI evaluation.
  • Patients with TMDS are secondary to malocclusion.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 19, 2025

First Posted

January 5, 2026

Study Start

January 1, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

January 1, 2027

Last Updated

January 6, 2026

Record last verified: 2025-12